NCT00079053 2023-08-04Adjuvant Erlotinib After Completing Chemoradiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and NeckCanadian Cancer Trials GroupPhase 1 Completed19 enrolled
NCT00404339 2016-04-18Vaccine Therapy in Treating Patients With Head and Neck CancerUniversity of PittsburghPhase 1 Completed17 enrolled